TY - JOUR AU - Moore, R. A. AU - Moore, O. A. AU - Derry, S. AU - Peloso, P. M. AU - Gammaitoni, A. R. AU - Wang, H. PY - 2010 DA - 2010// TI - Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.107805 DO - 10.1136/ard.2009.107805 ID - Moore2010 ER - TY - JOUR AU - Chan, F. K. AU - Cryer, B. AU - Goldstein, J. L. AU - Lanas, A. AU - Peura, D. A. AU - Scheiman, J. M. AU - Simon, L. S. AU - Singh, G. AU - Stillman, M. J. AU - Wilcox, C. M. AU - Berger, M. F. AU - Breazna, A. AU - Dodge, W. PY - 2010 DA - 2010// TI - A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract JO - J Rheumatol VL - 37 UR - https://doi.org/10.3899/jrheum.090168 DO - 10.3899/jrheum.090168 ID - Chan2010 ER - TY - JOUR AU - Garcia Rodriguez, L. A. AU - Jick, H. PY - 1994 DA - 1994// TI - Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs JO - Lancet VL - 343 UR - https://doi.org/10.1016/S0140-6736(94)91843-0 DO - 10.1016/S0140-6736(94)91843-0 ID - Garcia Rodriguez1994 ER - TY - JOUR AU - Laine, L. AU - Connors, L. G. AU - Reicin, A. AU - Hawkey, C. J. AU - Burgos-Vargas, R. AU - Schnitzer, T. J. AU - Yu, Q. AU - Bombardier, C. PY - 2003 DA - 2003// TI - Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use JO - Gastroenterology VL - 124 UR - https://doi.org/10.1053/gast.2003.50054 DO - 10.1053/gast.2003.50054 ID - Laine2003 ER - TY - JOUR AU - Allison, M. C. AU - Howatson, A. G. AU - Torrance, C. J. AU - Lee, F. D. AU - Russell, R. I. PY - 1992 DA - 1992// TI - Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs JO - N Engl J Med VL - 327 UR - https://doi.org/10.1056/NEJM199209103271101 DO - 10.1056/NEJM199209103271101 ID - Allison1992 ER - TY - JOUR AU - Bjarnason, I. AU - Williams, P. AU - So, A. AU - Zanelli, G. D. AU - Levi, A. J. AU - Gumpel, J. M. AU - Peters, T. J. AU - Ansell, B. PY - 1984 DA - 1984// TI - Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs JO - Lancet VL - 2 UR - https://doi.org/10.1016/S0140-6736(84)92739-9 DO - 10.1016/S0140-6736(84)92739-9 ID - Bjarnason1984 ER - TY - JOUR AU - Kearney, P. M. AU - Baigent, C. AU - Godwin, J. AU - Halls, H. AU - Emberson, J. R. AU - Patrono, C. PY - 2006 DA - 2006// TI - Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials JO - BMJ VL - 332 UR - https://doi.org/10.1136/bmj.332.7553.1302 DO - 10.1136/bmj.332.7553.1302 ID - Kearney2006 ER - TY - JOUR AU - McGettigan, P. AU - Henry, D. PY - 2006 DA - 2006// TI - Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2 JO - JAMA VL - 296 UR - https://doi.org/10.1001/jama.296.13.jrv60011 DO - 10.1001/jama.296.13.jrv60011 ID - McGettigan2006 ER - TY - JOUR AU - McGettigan, P. AU - Henry, D. PY - 2011 DA - 2011// TI - Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies JO - PLoS Med VL - 8 UR - https://doi.org/10.1371/journal.pmed.1001098 DO - 10.1371/journal.pmed.1001098 ID - McGettigan2011 ER - TY - JOUR AU - Solomon, D. H. AU - Glynn, R. J. AU - Rothman, K. J. AU - Schneeweiss, S. AU - Setoguchi, S. AU - Mogun, H. AU - Avorn, J. AU - Sturmer, T. PY - 2008 DA - 2008// TI - Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.23911 DO - 10.1002/art.23911 ID - Solomon2008 ER - TY - JOUR AU - Lanas, A. AU - Sopena, F. PY - 2009 DA - 2009// TI - Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications JO - Gastroenterol Clin North Am VL - 38 UR - https://doi.org/10.1016/j.gtc.2009.03.007 DO - 10.1016/j.gtc.2009.03.007 ID - Lanas2009 ER - TY - JOUR AU - Ng, S. C. AU - Chan, F. K. PY - 2010 DA - 2010// TI - NSAID-induced gastrointestinal and cardiovascular injury JO - Curr Opin Gastroenterol VL - 26 UR - https://doi.org/10.1097/MOG.0b013e32833e91eb DO - 10.1097/MOG.0b013e32833e91eb ID - Ng2010 ER - TY - JOUR AU - Hawkey, C. J. PY - 1999 DA - 1999// TI - COX-2 inhibitors JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)12154-2 DO - 10.1016/S0140-6736(98)12154-2 ID - Hawkey1999 ER - TY - JOUR AU - Goldstein, J. L. AU - Eisen, G. M. AU - Lewis, B. AU - Gralnek, I. M. AU - Aisenberg, J. AU - Bhadra, P. AU - Berger, M. F. PY - 2007 DA - 2007// TI - Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy JO - Aliment Pharmacol Ther VL - 25 UR - https://doi.org/10.1111/j.1365-2036.2007.03312.x DO - 10.1111/j.1365-2036.2007.03312.x ID - Goldstein2007 ER - TY - JOUR AU - Mamdani, M. AU - Rochon, P. A. AU - Juurlink, D. N. AU - Kopp, A. AU - Anderson, G. M. AU - Naglie, G. AU - Austin, P. C. AU - Laupacis, A. PY - 2002 DA - 2002// TI - Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs JO - BMJ VL - 325 UR - https://doi.org/10.1136/bmj.325.7365.624 DO - 10.1136/bmj.325.7365.624 ID - Mamdani2002 ER - TY - JOUR AU - Silverstein, F. E. AU - Faich, G. AU - Goldstein, J. L. AU - Simon, L. S. AU - Pincus, T. AU - Whelton, A. AU - Makuch, R. AU - Eisen, G. AU - Agrawal, N. M. AU - Stenson, W. F. AU - Burr, A. M. AU - Zhao, W. W. AU - Kent, J. D. AU - Lefkowith, J. B. AU - Verburg, K. M. AU - Geis, G. S. PY - 2000 DA - 2000// TI - Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial: Celecoxib Long-term Arthritis Safety Study JO - JAMA VL - 284 UR - https://doi.org/10.1001/jama.284.10.1247 DO - 10.1001/jama.284.10.1247 ID - Silverstein2000 ER - TY - JOUR AU - Singh, G. AU - Fort, J. G. AU - Goldstein, J. L. AU - Levy, R. A. AU - Hanrahan, P. S. AU - Bello, A. E. AU - Andrade-Ortega, L. AU - Wallemark, C. AU - Agrawal, N. M. AU - Eisen, G. M. AU - Stenson, W. F. AU - Triadafilopoulos, G. PY - 2006 DA - 2006// TI - Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study JO - Am J Med VL - 119 UR - https://doi.org/10.1016/j.amjmed.2005.09.054 DO - 10.1016/j.amjmed.2005.09.054 ID - Singh2006 ER - TY - JOUR AU - Chan, F. K. AU - Lanas, A. AU - Scheiman, J. AU - Berger, M. F. AU - Nguyen, H. AU - Goldstein, J. L. PY - 2010 DA - 2010// TI - Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60673-3 DO - 10.1016/S0140-6736(10)60673-3 ID - Chan2010 ER - TY - JOUR AU - Deeks, J. J. AU - Smith, L. A. AU - Bradley, M. D. PY - 2002 DA - 2002// TI - Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials JO - BMJ VL - 325 UR - https://doi.org/10.1136/bmj.325.7365.619 DO - 10.1136/bmj.325.7365.619 ID - Deeks2002 ER - TY - JOUR AU - Moore, R. A. AU - Derry, S. AU - Makinson, G. T. AU - McQuay, H. J. PY - 2005 DA - 2005// TI - Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports JO - Arthritis Res Ther VL - 7 UR - https://doi.org/10.1186/ar1704 DO - 10.1186/ar1704 ID - Moore2005 ER - TY - JOUR AU - Rostom, A. AU - Muir, K. AU - Dube, C. AU - Jolicoeur, E. AU - Boucher, M. AU - Joyce, J. AU - Tugwell, P. AU - Wells, G. W. PY - 2007 DA - 2007// TI - Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review JO - Clin Gastroenterol Hepatol VL - 5 UR - https://doi.org/10.1016/j.cgh.2007.03.011 DO - 10.1016/j.cgh.2007.03.011 ID - Rostom2007 ER - TY - JOUR AU - Castellsague, J. AU - Holick, C. N. AU - Hoffman, C. C. AU - Gimeno, V. AU - Stang, M. R. AU - Perez-Gutthann, S. PY - 2009 DA - 2009// TI - Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs JO - Pharmacotherapy VL - 29 UR - https://doi.org/10.1592/phco.29.12.1397 DO - 10.1592/phco.29.12.1397 ID - Castellsague2009 ER - TY - JOUR AU - Flather, M. D. AU - Farkouh, M. E. AU - Pogue, J. M. AU - Yusuf, S. PY - 1997 DA - 1997// TI - Strengths and limitations of meta-analysis: larger studies may be more reliable JO - Control Clin Trials VL - 18 UR - https://doi.org/10.1016/S0197-2456(97)00024-X DO - 10.1016/S0197-2456(97)00024-X ID - Flather1997 ER - TY - JOUR AU - Gavaghan, D. J. AU - Moore, R. A. AU - McQuay, H. J. PY - 2000 DA - 2000// TI - An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data JO - Pain VL - 85 UR - https://doi.org/10.1016/S0304-3959(99)00302-4 DO - 10.1016/S0304-3959(99)00302-4 ID - Gavaghan2000 ER - TY - JOUR AU - Moore, R. A. AU - Gavaghan, D. AU - Tramer, M. R. AU - Collins, S. L. AU - McQuay, H. J. PY - 1998 DA - 1998// TI - Size is everything: large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects JO - Pain VL - 78 UR - https://doi.org/10.1016/S0304-3959(98)00140-7 DO - 10.1016/S0304-3959(98)00140-7 ID - Moore1998 ER - TY - JOUR AU - Clarke, M. AU - Halsey, J. PY - 2001 DA - 2001// TI - DICE 2: a further investigation of the effects of chance in life, death and subgroup analyses JO - Int J Clin Pract VL - 55 ID - Clarke2001 ER - TY - JOUR AU - Cryer, B. AU - Li, C. AU - Simon, L. AU - Singh, G. AU - Stillman, M. AU - Berger, M. PY - 2012 DA - 2012// TI - GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial [abstract] JO - Arthritis Res Ther VL - 14 UR - https://doi.org/10.1186/ar3664 DO - 10.1186/ar3664 ID - Cryer2012 ER -